The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas
- 27 August 2012
- journal article
- Published by Elsevier BV in Neurochemistry International
- Vol. 61 (7), 1183-1191
- https://doi.org/10.1016/j.neuint.2012.08.011
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Elevated invasive potential of glioblastoma stem cellsBiochemical and Biophysical Research Communications, 2011
- L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1The EMBO Journal, 2011
- L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cellsCarcinogenesis: Integrative Cancer Research, 2010
- Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal AdenocarcinomaAnnals of Surgical Oncology, 2010
- Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic CancerCancer Research, 2009
- Targeting Cancer Stem Cells through L1CAM Suppresses Glioma GrowthCancer Research, 2008
- TGF-β, Neuronal Stem Cells and GlioblastomaOncogene, 2005
- L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasThe Lancet, 2003
- Prevalence estimates for primary brain tumors in the United States by behavior and major histology groupsNeuro-Oncology, 2001
- Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicinOncogene, 2001